3Mori A. Sensitization and onset of Japanese cedar pollinosis in children. Arerugi, 1995, 44:7-- 15.
4Taira H, Shouji T, Teranishi H, et al. Characteristics of pollen scattering from male sugi flowers in relation to occurring of symptoms in Japanese cedar pollenosis patients. Arerugi, 1995, 44:467--473.
5Ito Y, Takahashi Y, Fujita T, et al. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination. Auris Nasus Larynx, 1997, 24:163--170.
6Ito Y, Takahashi Y, Matsuura T, et al. The period of termination of nasal symptoms in Japanese cedar pollinosis patients and factors participating in the termination of symptoms. Arerugi, 1996, 45:1277--1284.
7Komiyama N, Sone T, Shimizu K, et al. cDNA cloning and expression of Cry j II the second major allergen of Japanese cedar pollen. Biochem Biophys Res Commun,1994, 201:1021-- 1028.
8Sone T, Morikuho K, Miyahara M, et al. T cell epitopes in Japanese cedar (cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-hased immunotherapeutics for the management of Japanese cedar pollinosis. J Immunol, 1998, 161:448--457.
9Namba M, Kurose M, Torigoe K, et al. Molecular cloning of the second major allergen, Cry j Ⅱ, from Japanese cedar pollen. FEBS Lett, 1994, 353:124--128.
10Ganbo T, Hisamatsu K, Inoue H, et al. Detection of specific IgE antibodies to Japanese cypress pollen in patients with nasal allergy: a comparative study with Japanese cedar. Auris Nasus Larynx, 1995, 22: 158-164.
